Ampol Limited
Ampol Limited (CTXAF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Ampol Limited (CTXAF), covering cash flow, earnings, and balance sheets.
Ampol Limited (CTXAF) Income Statement & Financial Overview
Review Ampol Limited CTXAF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $16.43B | $18.24B | $19.13B | $18.33B |
| Cost of Revenue | $15.73B | $16.81B | $17.52B | $17.35B |
| Gross Profit | $704.90M | $1.43B | $1.61B | $981.20M |
| Gross Profit Ratio | $0.04 | $0.08 | $0.08 | $0.05 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $888.60M | $961.60M | $940.40M | $854.60M |
| Operating Expenses | $850.50M | $939.20M | $940.40M | $854.60M |
| Total Costs & Expenses | -$16.58B | $17.75B | $18.46B | $18.20B |
| Interest Income | $2.10M | $4.60M | $4.70M | $6.60M |
| Interest Expense | $188.30M | $154.80M | $139.10M | $143.50M |
| Depreciation & Amortization | $249.80M | $164.70M | $237.20M | $221.70M |
| EBITDA | $319.80M | $654.20M | $1.04B | $457.30M |
| EBITDA Ratio | $0.02 | $0.04 | $0.05 | $0.02 |
| Operating Income | -$145.60M | $494.30M | $667.50M | $126.60M |
| Operating Income Ratio | -$0.009 | $0.03 | $0.03 | $0.007 |
| Other Income/Expenses (Net) | $27.30M | -$144.00M | -$4.90M | -$34.50M |
| Income Before Tax | -$118.30M | $350.30M | $662.60M | $92.10M |
| Income Before Tax Ratio | -$0.007 | $0.02 | $0.03 | $0.005 |
| Income Tax Expense | -$35.40M | $88.40M | $163.40M | -$11.90M |
| Net Income | -$112.70M | $235.20M | $470.00M | $79.10M |
| Net Income Ratio | -$0.007 | $0.01 | $0.02 | $0.004 |
| EPS | -$0.47 | $0.99 | $1.97 | $0.33 |
| Diluted EPS | -$0.47 | $0.98 | $1.97 | $0.33 |
| Weighted Avg Shares Outstanding | $238.30M | $238.30M | $238.30M | $238.30M |
| Weighted Avg Shares Outstanding (Diluted) | $238.30M | $239.30M | $238.82M | $238.70M |
Financial performance has remained strong, with revenue growing from $18.33B in Q2 2023 to $16.43B in Q4 2024. Gross profit continued to perform well, with margins at 4% in the latest quarter. Operating income reached -$145.60M in Q4 2024, holding a steady -1% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $319.80M. Net income dropped to -$112.70M, keeping EPS at -$0.47. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan